From: Lack of association between polymorphisms of MASP2and susceptibility to SARS coronavirus infection
SARS cases | controls | ||||||
---|---|---|---|---|---|---|---|
Genotype | P1 | P2 | C1 | C2 | P1 vs.P2 | C1vs.C2 | P1, P2 vs. C1, C2 |
(n = 272) | (n = 104) | (n = 232) | (n = 291) | P | P | P | |
rs2261695 | |||||||
AA | 189 (70.3%) |
73 (75.3%) | 174 (75.0%) |
193 (70.4%) | 0.35 | 0.25 | 0.76 |
AG |
77 (28.6%) |
22 (22.7%) |
56 (24.1%) |
78 (28.5%) | |||
GG |
3 (1.1%) |
2 (2.0%) |
2 (0.9%) |
3 (1.1%) | |||
rs2273346 | |||||||
TT | 186 (68.4%) |
64 (61.5%) |
147 (63.4%) |
190 (66.2%) | 0.21 | 0.50 | 0.63 |
TC | 78 (28.7%) |
36 (34.6%) |
71 (30.6%) |
82 (28.6%) | |||
CC |
8 (2.9%) |
4 (3.8%) |
14 (6%) |
15 (5.2%) | |||
rs12711521 | |||||||
TT |
105 (38.5%) |
58 (55.8%) |
106 (45.7%) |
139 (47.8%) | 0.003 | 0.64 | 0.30 |
TG |
137 (50.5%) |
36 (34.6%) |
95 (40.9%) |
108 (37.1%) | |||
GG |
30 (11.0%) |
10 (9.6%) |
31 (13.4%) |
44 (15.1%) | |||
rs7548659 | |||||||
TT |
173 (69.5%) |
70 (67.3%) |
157 (67.7%) |
205 (70.5%) | 0.69 | 0.50 | 0.91 |
TG | 61 (24.5%) |
25 (24.0%) |
67 (28.9%) |
75 (27.8%) | |||
GG |
15 (6.0%) |
9 (8.7%) |
8 (3.4%) |
11 (1.7%) | |||
Diplotypea | |||||||
TT |
344 (63.2%) |
128 (61.5%) |
304 (65.5%) |
380 (65.3%) | 0.89 | 1.00 | 0.31 |
TG |
108 (19.9%) |
42 (20.2%) |
60 (12.9%) |
76 (13.0%) | |||
CT |
6 (1.1%) |
4 (1.9%) |
2 (0.5%) |
4 (0.7%) | |||
CG |
86 (15.8%) |
34 (16.4%) |
98 (21.1%) |
122 (21.0%) |